Hyundai PALISADE Crowned 2026 North American Utility Vehicle of the Year
- All-new PALISADE honored by the North American Car, Utility and Truck of the Year (NACTOY) jury, one of the most respected independent automotive accolades
- Flagship three-row SUV praised for its hybrid and ICE powertrain lineup, class-above interior space, and advanced safety and convenience technologies
- NACTOY awards judged by 50 leading automotive journalists from the
U.S. andCanada , following extensive real-world evaluation
The NACTOY awards are determined by a jury of 50 independent automotive journalists from the
As Hyundai Motor's flagship three-row SUV, the all-new PALISADE was recognized for its broad and versatile powertrain lineup, including an efficient next-generation hybrid option alongside proven internal combustion engines. It also stood out for its spacious, premium interior, intuitive technology and comprehensive suite of family-oriented safety and convenience features.
"Palisade represents everything we strive to deliver at Hyundai — beautiful design, advanced technology, exceptional safety, and real value for families. To be recognized by 50 of
"Hyundai PALISADE defines the family vehicle for the 21st century. It's spacious, fun to drive and has a lot of technology. Congratulations on this impressive win." –
Founded in 1994, NACTOY is the longest-running new-vehicle awards program not affiliated with a single media outlet. Its independence, rigorous evaluation process, and diverse jury make the awards among the most credible and prestigious honors in the global automotive industry.
More information about Hyundai Motor and its products can be found at: https://www.hyundai.com/worldwide/en/ or Newsroom: Media Hub by Hyundai
View original content to download multimedia:https://www.prnewswire.com/news-releases/hyundai-palisade-crowned-2026-north-american-utility-vehicle-of-the-year-302661228.html
SOURCE Hyundai Motor Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting
- Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
- Lovery Real Estate Launches Homeowner Program for Renovation Guidance
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share